Article
The Semaglutide Battle: Why Drl Won The Right To Manufacture Despite Novo's Patent
On 2nd December 2025, the Delhi High Court declined to grant an interim injunction restraining Dr. Reddy's Laboratories from manufacturing semaglutide in India for export, notwithstanding Novo Nordisk's assertion of infringement of Indian patent IN 262697 (IN'697).
Khurana and Khurana